4-butyrolactone has been researched along with fosbretabulin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burnett, JC; Day, BW; Gussio, R; Hamel, E; Hermone, AR; McGrath, C; Nguyen, TL; Wipf, P; Zaharevitz, DW | 1 |
| Chiu, CT; Chung, TH; Jow, GM; Liao, CK; Lin, PC; Shen, CC; Wu, JC | 1 |
2 other study(ies) available for 4-butyrolactone and fosbretabulin
| Article | Year |
|---|---|
A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach.
Topics: 2-Methoxyestradiol; 4-Butyrolactone; Aminophenols; Binding Sites; Chalcone; Colchicine; Cyclopropanes; Estradiol; Indans; Lignans; Models, Molecular; Molecular Structure; Nocodazole; Podophyllotoxin; Protein Binding; Stilbenes; Structure-Activity Relationship; Sulfonamides; Thiazoles; Tubulin; Tubulin Modulators | 2005 |
HYS-32, a novel analogue of combretastatin A-4, enhances connexin43 expression and gap junction intercellular communication in rat astrocytes.
Topics: 4-Butyrolactone; Animals; Animals, Newborn; Antineoplastic Agents, Phytogenic; Astrocytes; Blotting, Western; Cell Communication; Cells, Cultured; Coloring Agents; Connexin 43; Enzyme Inhibitors; Female; Gap Junctions; Image Processing, Computer-Assisted; Male; Microscopy, Fluorescence; Naphthalenes; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Signal Transduction; Stilbenes; Tetrazolium Salts; Thiazoles | 2013 |